Helen E Seaman

Summary

Affiliation: University of Surrey
Country: UK

Publications

  1. ncbi Differences in the use of combined oral contraceptives amongst women with and without acne
    H E Seaman
    Pharmacoepidemiology Unit, Postgraduate Medical School University of Surrey, Stirling House, Stirling Road, Surrey Research Park, Guildford, Surrey GU2 7DJ, UK
    Hum Reprod 18:515-21. 2003
  2. ncbi The risk of venous thromboembolism in women prescribed cyproterone acetate in combination with ethinyl estradiol: a nested cohort analysis and case-control study
    H E Seaman
    Pharmacoepidemiology Unit, Postgraduate Medical School University of Surrey, Stirling House, Stirling Road, Surrey Research Park, Guildford, Surrey GU2 7DJ, UK
    Hum Reprod 18:522-6. 2003
  3. ncbi The risk of liver disorders in women prescribed cyproterone acetate in combination with ethinyloestradiol (Dianette): a nested case-control study using the GPRD
    H E Seaman
    Department of Pharmacoepidemiology, Postgraduate Medical School E5, University of Surrey, Stirling House, Surrey Research Park, Guildford, GU2 7DJ, UK
    Pharmacoepidemiol Drug Saf 12:541-50. 2003
  4. ncbi Venous thromboembolism associated with cyproterone acetate in combination with ethinyloestradiol (Dianette): observational studies using the UK General Practice Research Database
    H E Seaman
    Pharmacoepidemiology Unit, Postgraduate Medical School, University of Surrey, Surrey, UK
    Pharmacoepidemiol Drug Saf 13:427-36. 2004
  5. ncbi Venous thromboembolism and cyproterone acetate in men with prostate cancer: a study using the General Practice Research Database
    Helen E Seaman
    Department of Pharmacoepidemiology, Postgraduate Medical School University of Surrey, Guildford, UK
    BJU Int 99:1398-403. 2007

Detail Information

Publications5

  1. ncbi Differences in the use of combined oral contraceptives amongst women with and without acne
    H E Seaman
    Pharmacoepidemiology Unit, Postgraduate Medical School University of Surrey, Stirling House, Stirling Road, Surrey Research Park, Guildford, Surrey GU2 7DJ, UK
    Hum Reprod 18:515-21. 2003
    ..The use of CPA/EE steadily increased after its introduction to the UK market in 1987, but there was a marked increase in its share of the OC market after 1995...
  2. ncbi The risk of venous thromboembolism in women prescribed cyproterone acetate in combination with ethinyl estradiol: a nested cohort analysis and case-control study
    H E Seaman
    Pharmacoepidemiology Unit, Postgraduate Medical School University of Surrey, Stirling House, Stirling Road, Surrey Research Park, Guildford, Surrey GU2 7DJ, UK
    Hum Reprod 18:522-6. 2003
    ..We believe the results of those studies may have been affected by residual confounding...
  3. ncbi The risk of liver disorders in women prescribed cyproterone acetate in combination with ethinyloestradiol (Dianette): a nested case-control study using the GPRD
    H E Seaman
    Department of Pharmacoepidemiology, Postgraduate Medical School E5, University of Surrey, Stirling House, Surrey Research Park, Guildford, GU2 7DJ, UK
    Pharmacoepidemiol Drug Saf 12:541-50. 2003
    ..CPA/EE is licensed in the UK for the treatment of women with acne and hirsutism and is a treatment option for polycystic ovary syndrome (PCOS). It acts as a contraceptive also...
  4. ncbi Venous thromboembolism associated with cyproterone acetate in combination with ethinyloestradiol (Dianette): observational studies using the UK General Practice Research Database
    H E Seaman
    Pharmacoepidemiology Unit, Postgraduate Medical School, University of Surrey, Surrey, UK
    Pharmacoepidemiol Drug Saf 13:427-36. 2004
    ..CPA/EE provides a treatment option for women with polycystic ovary syndrome (PCOS). CPA/EE has been associated with an increased risk of VTE...
  5. ncbi Venous thromboembolism and cyproterone acetate in men with prostate cancer: a study using the General Practice Research Database
    Helen E Seaman
    Department of Pharmacoepidemiology, Postgraduate Medical School University of Surrey, Guildford, UK
    BJU Int 99:1398-403. 2007
    ..To evaluate the risk of venous thromboembolism (VTE) associated with the use of cyproterone acetate (CPA) amongst men with prostate cancer...